Poxviridae treatment

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/39 (2006.01) A61K 38/17 (2006.01) A61K 39/275 (2006.01) A61K 48/00 (2006.01) A61P 31/20 (2006.01)

Patent

CA 2673757

A vaccine composition for combating Pox viridae viral infections in living organisms such as mammals (including humans) comprises TAP-1 and/or TAP-2 to augment the antigen processing capability of infected cells and hence their immunogenicity. The composition may be used alone or, preferably, as an immunogenicity-enhancing adjuvant with pox antigen-based vaccine in treatment or prophylaxis especially of smallpox viral infections.

L'invention concerne une composition de vaccin pour combattre des infections virales à Poxviridae chez des organismes vivants tels que les mammifères (y compris, les êtres humains). La composition de vaccin comprend TAP-1 et/ou TAP-2 pour augmenter l'aptitude au traitement des antigènes de cellules infectées et par conséquent leur immunogénicité. La composition peut être utilisée seule ou, de préférence, en tant qu'adjuvant améliorant l'immunogénicité avec un vaccin à base d'antigène du virus Pox dans le traitement ou la prophylaxie, notamment d'infections virales de la variole.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Poxviridae treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Poxviridae treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Poxviridae treatment will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1601891

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.